Canadian Weed Producer Reduces Net Loss For 2023 But Reports Higher Debt

Zinger Key Points
  • Red White & Bloom Brands reported fiscal 2023 revenues of CA$88.3 million, compared to CA$87.7 million in fiscal 2022.  
Loading...
Loading...

Canadian marijuana company Red White & Bloom Brands Inc. RWB RWBYF reported its financial results Monday for the fourth quarter and fiscal year 2023, revealing quarterly revenue of CA$19.9 million ($14.5 million), compared to CA$15.4 million in the same period of 2022. For the fiscal year 2023, the Toronto-based operator reported revenues of CA$88.3 million, compared to CA$87.7 million in fiscal 2022.  

"RWB continued to effect value-added transformations of its business during fiscal 2023," stated Colby De Zen, president and director. "We focused on higher margin revenue opportunities and sunsetting of low margin products, as can be seen in our results, which has led to a 30% increase in gross margin with revenue only increasing marginally over the same period. Moving into fiscal 2024, the company has targeted several near-term priorities, including a fulsome restructuring of its current financing arrangements, resourcing its key business segments, both in Canada and across incumbent and prospective US states, providing a path for our company and its valued team members to achieve profitable growth and sustainable liquidity."  

Grow your cannabis business and raise capital at Benzinga’s New Jersey Market Spotlight on June 17. Network with key industry players, hear from the top operators and close deals that will shape the future. Act now— spots are filling fast. Get your tickets here

Q4 2023 Results Compared To Q4 2022

  • Gross profit was CA$7.4 million, compared to CA$1.3 million. 
  • Net loss amounted to CA$118.1 million, versus net loss of CA$206.1 million. 
  • Adjusted EBITDA was a gain of CA$1.7 million, compared to an Adjusted EBITDA loss of CA$3.2 million. 

FY 2023 Results Compared To FY 2022 

  • Gross profit was CA$31.2 million, which compares to CA$22.5 million. 
  • Adjusted EBITDA was a gain of CA$5.5 million, versus CA$7.2 million. 
  • Operating expenses were CA$11.0 million, compared to CA$7.4 million.
  • Net loss amounted to CA$143.6 million, which compares to a net loss of CA$242.1 million. 
  • At the end of 2023, the company had reported a debt of CA$240 million, compared to a debt of CA$171.8 million at the end of 2022. 

Related Links: 

4/20 Cannabis Retail Frenzy: Leading Brands Ready For Record Sales Surge – Who Will Lead? Fast Track Recap: Colorado & Michigan Weed Sales Decline, Virginia Eyes Legal Market, Stock Winners & LosersToronto Weed Producer Seals Deal For Over $100M In Annual Revenue As RWB Finalizes Aleafia Health Buyout

Photo: Courtesy of Ryland zweifel via Shutterstock

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: CannabisEarningsNewsColby De Zen
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on bzcannabis.com – Prices will increase very soon!


Loading...